Receptor-avid exogenous optical contrast and therapeutic agents
View Patent ↗Cyanine and Indocyanine dye compounds and bioconjugates are disclosed. The present invention includes several cyanine and indocyanine dyes, including bioconjugates of the same, with a variety of bis- and tetrakis (carboxylic acid) homologues. The compounds of the invention may be conjugated to bioactive peptides, carbohydrates, hormones, drugs, or other bioactive agents. The small size of compounds of the invention allows favorable delivery to tumor cells as compared to larger molecular weight imaging agents. Further, use of a biocompatible organic solvent such as dimethylsulfoxide may be said to assist in maintaining the fluorescence of compounds of the invention. The compounds and bioconjugates herein disclosed are useful in a variety of medical applications including, but not limited to, diagnostic imaging and therapy, endoscopic applications for the detection of tumors and other abnormalities, localized therapy, photoacoustic tumor imaging, detection and therapy, and sonofluorescence tumor imaging, detection and therapy.
1. A compound of the following formula, wherein:
each A is independently —CH 2 or —CH 2 OCH 2 ;
R is —CONH-peptide;
R′ is R or —COOH; and
each n is independently 1-6.
2. The compound of claim 1 , wherein R′ is R.
3. The compound of claim 1 , wherein R′ is —COOH.
4. The compound of claim 1 , wherein peptide is octreotide.
5. The compound of claim 1 , wherein peptide is octreotate.
6. The compound of claim 1 , wherein peptide is bombesin.
7. The compound of claim 1 , wherein peptide is cholecystokinin.
8. The compound of claim 1 , wherein peptide is neurotensin.
9. The compound of claim 1 , wherein n is 1.
10. The compound of claim 1 , wherein n is 4.
11. The compound of claim 1 , wherein n is 6.
12. The compound of claim 1 , wherein each A is —CH 2 , and each n is 1.
13. The compound of claim 12 , wherein R′ is —COOH.
14. The compound of claim 13 , wherein peptide is octreotate.
15. The compound of claim 13 , wherein peptide is octreotide.
16. The compound of claim 13 , wherein peptide is octreotate.
17. The compound of claim 13 , wherein peptide is bombesin.
18. The compound of claim 13 , wherein peptide is cholecystokinin.
19. The compound of claim 13 , wherein peptide is neurotensin.
20. The compound of claim 12 , wherein R′ is R, and peptide is octreotate.